Works matching IS 13520504 AND DT 2020 AND VI 27 AND IP 3
Results: 13
Disentangling the lifespans of hepatitis C virus‐infected cells and intracellular vRNA replication‐complexes during direct‐acting anti‐viral therapy.
- Published in:
- Journal of Viral Hepatitis, 2020, v. 27, n. 3, p. 261, doi. 10.1111/jvh.13229
- By:
- Publication type:
- Article
Loss to follow‐up: A significant barrier in the treatment cascade with direct‐acting therapies.
- Published in:
- Journal of Viral Hepatitis, 2020, v. 27, n. 3, p. 243, doi. 10.1111/jvh.13228
- By:
- Publication type:
- Article
Prevalence and burden of HBV co‐infection among people living with HIV: A global systematic review and meta‐analysis.
- Published in:
- Journal of Viral Hepatitis, 2020, v. 27, n. 3, p. 294, doi. 10.1111/jvh.13217
- By:
- Publication type:
- Article
Outcome of cutaneous psoriasis in hepatitis C virus‐infected patients treated with Direct‐Acting Antiviral therapy.
- Published in:
- Journal of Viral Hepatitis, 2020, v. 27, n. 3, p. 333, doi. 10.1111/jvh.13230
- By:
- Publication type:
- Article
Insights for clinical diagnostic indicators of virus and host in chronic hepatitis B infection.
- Published in:
- Journal of Viral Hepatitis, 2020, v. 27, n. 3, p. 224, doi. 10.1111/jvh.13260
- By:
- Publication type:
- Article
Hepatitis C virus testing, liver disease assessment and treatment uptake among people who inject drugs pre‐ and post‐universal access to direct‐acting antiviral treatment in Australia: The LiveRLife study.
- Published in:
- Journal of Viral Hepatitis, 2020, v. 27, n. 3, p. 281, doi. 10.1111/jvh.13233
- By:
- Publication type:
- Article
Real‐world impact following initiation of interferon‐free hepatitis C regimens on liver‐related outcomes and all‐cause mortality among patients with compensated cirrhosis.
- Published in:
- Journal of Viral Hepatitis, 2020, v. 27, n. 3, p. 270, doi. 10.1111/jvh.13232
- By:
- Publication type:
- Article
Hepatitis B virus pregenomic RNA status can reveal the long‐term prognoses of chronic hepatitis B patients treated with nucleos(t)ide analogues.
- Published in:
- Journal of Viral Hepatitis, 2020, v. 27, n. 3, p. 323, doi. 10.1111/jvh.13227
- By:
- Publication type:
- Article
HCV in the haemodialysis population: Treat now or later?
- Published in:
- Journal of Viral Hepatitis, 2020, v. 27, n. 3, p. 233, doi. 10.1111/jvh.13224
- By:
- Publication type:
- Article
Issue Information.
- Published in:
- Journal of Viral Hepatitis, 2020, v. 27, n. 3, p. 221, doi. 10.1111/jvh.13136
- Publication type:
- Article
Long‐term morbidity and mortality in a Canadian post‐transfusion hepatitis C cohort: Over 15 years of follow‐up.
- Published in:
- Journal of Viral Hepatitis, 2020, v. 27, n. 3, p. 235, doi. 10.1111/jvh.13226
- By:
- Publication type:
- Article
Comparing interferon‐free with interferon‐based regimens in HCV patients: Rogers phenomenon and Simpson's paradox.
- Published in:
- Journal of Viral Hepatitis, 2020, v. 27, n. 3, p. 329, doi. 10.1111/jvh.13225
- By:
- Publication type:
- Article
An observational study on long‐term renal outcome in patients with chronic hepatitis B treated with tenofovir disoproxil fumarate.
- Published in:
- Journal of Viral Hepatitis, 2020, v. 27, n. 3, p. 316, doi. 10.1111/jvh.13222
- By:
- Publication type:
- Article